184 related articles for article (PubMed ID: 15909810)
1. [Gemcitabine plus cisplatin therapy in breast cancer refractory to anthracyclines, docetaxel and capecitabine].
Semiglazova TIu; Filatova LV; Gershanovich ML
Vopr Onkol; 2005; 51(1):66-70. PubMed ID: 15909810
[TBL] [Abstract][Full Text] [Related]
2. Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.
Mackey JR; Tonkin KS; Koski SL; Scarfe AG; Smylie MG; Joy AA; Au HJ; Bodnar DM; Soulieres D; Smith SW
Clin Breast Cancer; 2004 Oct; 5(4):287-92. PubMed ID: 15507175
[TBL] [Abstract][Full Text] [Related]
3. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.
Sánchez-Escribano Morcuende R; Alés-Martínez JE; Aramburo González PM
Clin Transl Oncol; 2007 Jul; 9(7):459-64. PubMed ID: 17652060
[TBL] [Abstract][Full Text] [Related]
4. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer.
Chan S; Romieu G; Huober J; Delozier T; Tubiana-Hulin M; Schneeweiss A; Lluch A; Llombart A; du Bois A; Kreienberg R; Mayordomo JI; Antón A; Harrison M; Jones A; Carrasco E; Vaury AT; Frimodt-Moller B; Fumoleau P
J Clin Oncol; 2009 Apr; 27(11):1753-60. PubMed ID: 19273714
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer.
Lin PC; Wang WS; Yang MH; Yen CC; Chao TC; Hsiao LT; Chen PM
J Chin Med Assoc; 2006 Jul; 69(7):304-9. PubMed ID: 16903643
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
Andres R; Mayordomo JI; Lara R; Lastra R; Ortega E; Polo E; Lambea J; Isla D; Saenz-Cusi A; Escudero P; Tres A
Clin Breast Cancer; 2005 Jun; 6(2):158-62. PubMed ID: 16001994
[TBL] [Abstract][Full Text] [Related]
7. A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.
Bayo J; Lomas M; Salvador J; Moreno A; Ruiz M; Rodríguez A; Fuentes J; Fernández-Freire A; Bernabé R; Fernández A
Clin Transl Oncol; 2008 Dec; 10(12):817-25. PubMed ID: 19068453
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
Levy C; Fumoleau P
Cancer Treat Rev; 2005; 31 Suppl 4():S17-22. PubMed ID: 16360543
[TBL] [Abstract][Full Text] [Related]
9. Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.
Park JS; Jeung HC; Rha SY; Ahn JB; Kang B; Chon HJ; Hong MH; Lim S; Yang WI; Nam CM; Chung HC
Cancer Chemother Pharmacol; 2014 Oct; 74(4):799-808. PubMed ID: 25107569
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
[TBL] [Abstract][Full Text] [Related]
11. Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG).
Tomova A; Bartsch R; Brodowicz T; Tzekova V; Timcheva C; Wiltschke C; Gerges DA; Pawlega J; Spanik S; Inbar M; Zielinski CC
Breast Cancer Res Treat; 2010 Jan; 119(1):169-76. PubMed ID: 19768533
[TBL] [Abstract][Full Text] [Related]
12. Overview of gemcitabine activity in advanced breast cancer.
Smith IE
Semin Oncol; 2006 Jun; 33(3 Suppl 9):S19-23. PubMed ID: 16797378
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
Seidman AD; Brufsky A; Ansari RH; Hart LL; Stein RS; Schwartzberg LS; Stewart JF; Russell CA; Chen SC; Fein LE; De La Cruz Vargas JA; Kim SB; Cavalheiro J; Zhao L; Gill JF; Obasaju CK; Orlando M; Tai DF
Ann Oncol; 2011 May; 22(5):1094-1101. PubMed ID: 21084429
[TBL] [Abstract][Full Text] [Related]
14. A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Kouroussis Ch; Papakotoulas P; Kalbakis K; Tryfonidis K; Vardakis N; Poppis E; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 May; 69(5):1345-52. PubMed ID: 22349809
[TBL] [Abstract][Full Text] [Related]
15. Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment.
Wang J; Fan Y; Xu B
Cancer Chemother Pharmacol; 2010 Aug; 66(3):597-603. PubMed ID: 20490795
[TBL] [Abstract][Full Text] [Related]
16. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
[TBL] [Abstract][Full Text] [Related]
18. Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.
Stemmler HJ; diGioia D; Freier W; Tessen HW; Gitsch G; Jonat W; Brugger W; Kettner E; Abenhardt W; Tesch H; Hurtz HJ; Rösel S; Brudler O; Heinemann V
Br J Cancer; 2011 Mar; 104(7):1071-8. PubMed ID: 21407218
[TBL] [Abstract][Full Text] [Related]
19. Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.
Donadio M; Ardine M; Berruti A; Beano A; Bottini A; Mistrangelo M; Bonardi S; Castiglione F; Generali D; Polimeni MA; Bretti S; Alabiso O; Bertetto O;
Oncology; 2005; 69(5):408-13. PubMed ID: 16319512
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Benekli M; Yildiz R; Uner A; Er O; Yamac D; Alkis N; Coskun U; Camci C; Buyukberber S
Oncology; 2007; 72(5-6):308-13. PubMed ID: 18198492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
